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Objective: To establish a surveillance in Dong Thap, at the border with Cambodia by
assessing the presence of DENV serotypes and CHIKV among patients hospitalized at
Dong Thap general hospital.
Methods: Cross-sectional descriptive analysis was conducted on a cohort of 131 patients
hospitalized with acute fever and symptoms compatible with dengue or chikungunya. The
study was conducted from January 2012 to February 2013. The full clinical picture was
established as well as serological and molecular detection. Serological analysis was
sequentially performed on blood samples collected on admission and an average of seven
days after admission. The detection of IgM antibody to DENV was performed by IgM
capture ELISA and the detection of DENV and CHIKV RNA was done by reverse-
transcription multiplex PCR.
Results: 101 patients out of 131 (77%) were conﬁrmed with dengue. All four dengue
serotypes were detected with a predominance of DENV2 and DENV4. No chikungunya
infection was detected although reported in neighboring Cambodia. A differential efﬁ-
ciency of serological dengue detection was observed. Efﬁciency was 29% upon admis-
sion and 53% after seven days on the same patients. 30 patients out of 131 (23%) were
negative with both DENV and CHIKV.
Conclusions: Dengue is at risk of being underestimated and chikungunya is not sys-
tematically detected. Changes in detection and surveillance procedures are therefore
discussed to increase efﬁciency of dengue detection and continue the monitoring the
emergence of CHIKV in Dong Thap province and in Vietnam.1. Introduction
Arthropod-borne viral infections (or arboviral infections) are
common causes of fever syndromes worldwide and more than
100 kinds of arboviruses are known to cause disease in humans
[1–3]. Dengue fever is caused by a ﬂavivirus belonging to the
family of Flaviviridae [4] while the chikungunya virus
(CHIKV) is an alphavirus from the family Togaviridae [5–7].Both dengue and chikungunya diseases are transmitted by
Aedes aegypti and Aedes albopictus [6,8] and can cause
potentially severe and or debilitating chronic disease [9]. While
dengue has been recorded as the most rapidly spreading
mosquito-borne viral disease in the world [10,11], chikungunya
has recently re-emerged after an interval of several decades. It
represents a risk for millions of people in the Indian Ocean areas,
Africa, Southeast Asia and more recently has spread to the
Caribbean, Paciﬁc and Europe [12–14]. Coinfection with dengue
virus (DENV) and CHIKV has been reported on patients from
Asian, African and Paciﬁc countries [15–19].
Vietnam is a hyperendemicity country with all four serotypes
being present all year long throughout the country [20], but
affecting mostly the southern part with major seasonal outbreaksunder the CC BY-NC-ND license (http://
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dengue fever epidemics have become more frequent and
widespread with an increasing number of cases and deaths over
the past 15 years [21,22]. From 1963 to 1995, 1518808 dengue
hemorrhagic fever (DHF) cases and 14133 deaths were reported
[22,23]. The dengue surveillance program in the Southern
Vietnam has demonstrated the occurrence of epidemic peaks of
higher magnitude approximately every 5 years from 1975 to
1987 [24]. Following an 11-year gap a major outbreak of
119429 DHF cases and 342 fatalities occurred in 1998 [24].
592938 dengue cases were reported during the 2001–2010
decade in 19 southern Vietnam provinces, which corresponds to
a median annual incidence of 232 cases per 100000 [20].
DENV and CHIKV are both transmitted by the same mos-
quito species, A. aegypti and A. albopictus. Although chi-
kungunya was ﬁrst described in Vietnam in the 1960's [25],
serological evidence of its presence remain scarce and is
mainly associated to the Vietnam War era. In 1966, ten
American soldiers were identiﬁed to be infected with CHIKV
[26] and serological surveys among children have detected anti-
CHIKV antibodies as early as 1967 [27]. Cambodia which has
a long and extensive border with Vietnam, is not only
endemic for dengue, but also for chikungunya which has
developed recently [28]. Both diseases can easily be imported
by travelers, spread rapidly through common vectors and
result in social, economic and healthcare system impacts.
Vietnam is at risk to be like Cambodia affected both by
dengue and chikungunya and be an overlapping area of distri-
bution for both viruses. Furthermore, owing to the similarity in
clinical manifestations and differences in clinical management,
clinicians should be aware of the need to include CHIKV in the
differential diagnosis of dengue fever. The aim of the study was
therefore to assess, through a dual screening of clinical samples
of acute febrile episode patients in Dong Thap general hospital
in Southern Vietnam, the respective prevalence of dengue and
chikungunya.Figure 1. Location and map of the Dong Thap province.2. Material and methods
2.1. Cohort design and ethical clearance
The study was approved by the Institutional Review Board of
National Institute of Hygiene and Epidemiology, Hanoi, Viet-
nam (No: 14IRB July 23, 2012) in charge of ethical clearance.
Patients were eligible for recruitment if they were admitted to the
infectious diseases department of Dong Thap general hospital
between January 1, 2012 and February 28, 2013. All hospital-
ized patients with suspected arbovirus infection were eligible for
participating in this study provided they displayed acute fever in
addition to two of any of the following symptoms: headache,
rash, myalgia, joint pain and arthralgia.
2.2. Study setting
Dong Thap general hospital is located in Cao Lanh city, Dong
Thap province. The province is located in theMekong delta region
in southern Vietnam, and bordered with Cambodia to the north
(Figure 1). Dong Thap is characterized by a typical tropical
climate with two distinctive seasons: The rainy season from May
to November and the dry season from December to April. The
annual average temperature is around 26 C. Dong Thap is one of
the provinces of southern Vietnam with people movement from
Cambodia and display a high rate of dengue infection.
2.3. Patient enrollment, clinical sample and data
management
After obtaining informed consent from patients, a total of 131
paired blood samples were collected from January 2012 to
February 2013 from acute fever cases suspected to be infected
by dengue within 1–14 d from the day onset of illness according
to WHO guidelines [2,29]. The collection of clinical samples was
performed twice and 3 mL or 5 mL of blood were collected each
Table 1
Frequency of symptoms on admission to Dong Thap general hospital
(n = 131).
Signs and
symptoms
Value Odds
ratio (OR)
<18 years
(n = 98)
>18 years
(n = 33)
P-value
Headache 88.5% 12.10 84.7 97.0% 0.062 5
Myalgia 72.0% 2.54 75.5 60.6% 0.090 0
Arthralgia 40.5% 0.70 31.6 66.6% 0.003 9
Rash 12.2% 0.14 10.0 18.0% 0.220 0
Petechiae 19.0% 0.20 20.4 15.0% 0.500 0
Nausea/Vomit 3.8% 0.03 3.0 6.0% 0.430 0
Positive
Tourniquet test
16.8% 0.25 14.3 24.2% 0.180 0
Note: Value are the mean (range) or number (%). P calculated by Chi
square test and ﬁsher test.
Table 2
Results of diagnostic tests for suspected dengue patients in Dong Thap,
Vietnam.
Diagnostic
test
Phase Type of
sample
No. of
samples
tested
No. of
positive
samples
% Positive
cases
IgM capture
ELISA
Acute Plasma 131 38 29
Serum 131 18 14
Convalescent Serum 131 70 53
Multiplex
PCR
Acute Plasma 131 97 74
Serum 131 95 73
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from onset of illness and then divided into two tubes: One
tube for serum analysis and the other one for plasma analysis;
(2) Ten to ﬁfteen days later, in convalescent phase, a second
blood sample was collected from the same patients. Samples
were kept at −20 C and kept at −80 C for virological
diagnosis by ELISA and PCR. For each patient, the collected
information included a unique identiﬁcation number and
demographic data such as full name, age, gender, residential
address, day of onset, date of ﬁrst and second sample
collection. Signs and symptoms were recorded on the day of
admission. Samples were coded prior to laboratory analysis.
2.4. RNA extraction and cDNA synthesis
The viral RNA was extracted from 140 mL of sample using
the QIAamp viral RNA Mini kit (QIAgen, Hildden, Germany).
Elution was performed in 60 mL according to the supplier and
RNA stored at −80 C until further use. RNA was reverse
transcribed into cDNA using Super transcript Ⅲ reverse tran-
scriptase (RT – Invitrogen). RNA template was mixed with
DNase, incubated at 37 C for 30 min and then 75 C for 15 min,
reverse transcription mix was then added and incubated at 65 C
for 5 min and then transferred in ice immediately. To prepare
double-stranded cDNA, annealing was performed at 25 C for
5 min, followed by extension at 42 C for 60 min, and inacti-
vation by holding the mixture at 75 C for 15 min.
2.5. Laboratory conﬁrmation of dengue and chikungunya
Detection of DENV and CHIKV was conducted both by a
Dengue IgM capture ELISA in ﬁrst samples (plasma and serum)
and second samples (serum) and by amultiplex PCR ampliﬁcation
for both ﬁrst and second samples. IgM antibody-capture enzyme
linked immunosorbent assay (MAC-ELISA)was conducted using
the Capture DxSelect™ kit made in CDC Fort Collins, United
States according to the supplier. PCR detection of DENV and
CHIKVwas conducted in a one-step, single tube serotype speciﬁc
assay using double-stranded cDNA templates as previously
described [30,31]. The ampliﬁcation was carried out in 50 mL
reaction volume with DENV a group-speciﬁc consensus forward
primer and four serotype-speciﬁc reverse primers. Nonstructural
protein 2 (nsP2) primerswere used for the detection ofCHIKV.All
relevant aspects of the PCR reaction (Master Mix, Primer, Tag
polymerase, number of cycles and annealing temperature) were
initially optimized using a quantitated puriﬁedDENVds-cDNA to
achieve a maximum level of sensitivity. Target RNA was ampli-
ﬁed in 50 mL volume containing 5 mL of DNAwas combined with
10 pmol of each speciﬁc primer DENV 1–4. PCR was conducted
with 35 cycles under the following conditions: denaturation at
94 C for 2 min, annealing at 57 C for 45 s and extension at 72 C
for 1.30 min with a ﬁnal extension at 72 C for 10 min. PCR
products were analyzed by Agarose gel electrophoresis in Tris-
acetate – EDTA (TAE) buffer. The expected size of amplicons
were 492 bp (DENV1), 119 bp (DENV2), 290 bp (DENV3), 392
bp (DENV4) ad 120 bp (CHIKV).
2.6. Data analysis
All the results were summarized in terms of medians and
ranges for continuous data, odds ratio (OR), Chi square and
Fishers exact tests were used as appropriate. Data for studyclinical symptom of patients was compared, which includes age,
gender, province and district.
3. Results
3.1. Clinical features
A total of 131 eligible DHF suspected cases were enrolled at
Dong Thap general hospital over 13 months starting in January
2012. 114 patients were from 11 districts in the Dong Thap
province, 16 patients from neighboring provinces such as An
Giang and 1 case from Ho Chi Minh City. The cohort comprised
62 females and 69 males, ranging in age from 5 months to 49
years with a median age of 15 years. The mean body tempera-
ture of patients on the day of admission was 39 C, and fever
was observed from 37.5 to 40.5 C of patients. The most
common clinical features observed were: headache (88.5%),
myalgia (72.0%), arthralgia (40.5%), rash (12.2%) a positive
tourniquet test (16.8%), and nausea/vomiting (3.8%) The mean
length of time to admission was 4 d after reported onset of fever
ranging from 1 to 7 d. The ﬁrst blood sample occurred in a
median time of 4 d (1–7 d) after onset (time of admission) while
the second blood sample was taken at median time of 7 d after
admission (7–14 d) (Table 1).
3.2. Prevalence of dengue and chikungunya in Dong
Thap hospital
Among the 131 acute fever patients enrolled in the cohort,
none of them were found to have been infected with chi-
kungunya. All CHIKV PCR tests proved to be negative. How-
ever, results were totally different with respect to dengue and
were dependent upon the detection method implemented and on
Table 3
Distribution of dengue serotypes among positive patients in Dong Thap
hospital, Vietnam.
Age No. of
DENV
patients
No. of
males
No. of
females
Dengue serotypes
DENV1 DENV2 DENV3 DENV4
0–4 8 3 5 0 3 5 0
5–14 55 25 30 7 20 11 17
15–24 19 8 11 1 6 2 10
25–34 14 8 6 2 6 0 6
>35 5 2 3 1 1 1 2
Total 101 46 55 11 36 19 35
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paired serum/plasma samples collected on the day of admission
(ﬁrst sample collection) during the acute phase, 38 patients
(29%) were dengue-positive when analyzing sera samples
whereas 18 (14%) patients only were positive when using the
plasma fraction (Table 2). When analyzing sera from conva-
lescent patients, i.e. second collection time, the number of IgM
positive samples rose to 70 (53%) (Table 2).
3.3. Distribution of dengue serotypes in Dong Thap
positive dengue cases
101 samples (77%) out of 131 collected were positive for
dengue. All four dengue serotypes were identiﬁed and the
respective number of positive was 11 (11%) for DENV1, 36
(36%) for DENV2, 19 (19%) for DENV3, and 35 (35%) for
DENV4 (Table 3). Males were more affected than females
(Table 3). Age was another discriminative criterion with the 5–
14 year class comprising 54.5% of all cases (55 out of 101)
(Table 3).
4. Discussion
The initial objective of this work was to assess within 13
months the occurrence of dengue and chikungunya among pa-
tients from Dong Thap general hospital admitted for acute fever
and dengue/chikungunya-related symptoms. The most common
symptoms on the day of admission were headache, fever,
myalgia, arthralgia, and a positive tourniquet test. Although the
majority of clinical manifestations were similar between adult
and pediatric patients, adults were signiﬁcantly more affected by
arthralgia than pediatric patients. More males were found to be
affected than females which correspond to other reports from
Nepal, China and Vietnam [32–34]. The most affected age class
was the 5–14 years class which in agreement with other
studies which have reported dengue mainly in children [33–39].
The co-circulation of four serotypes of DENV is in agree-
ment with the status of region of hyperendemicity of both
southern Vietnam and Cambodia [38,40,41]. However, if the
overall predominance recorded in this work is for DENV2
and DENV4, reports from Cambodia have stressed the
predominance of DENV2 and DENV3 with a rotation and
regular replacement of serotypes [40,41]. Dong Thap is located
along the Mekong River at the Cambodian border where cases
of chikungunya have been described along the major
northwest to southwest routes and in provinces bordering
Vietnam [28]. This dynamic of expansion might lead to
emergence in neighboring Vietnam provided that theCambodian–Vietnamese border in Dong Thap is a highly
active zone of transboundary movements. Although, the 13-
months surveillance described in this work did not show any
presence of CHIKV, but the risk is still present and this
surveillance should be maintained.
An important outcome from this work is the differential ef-
ﬁciency of detection of dengue through serology. DENV
infection was hardly detected in acute phase through serological
tests with only 29% of plasma and 14% of sera to be positive.
Conversely, DENV infection was detected at 53% in clinical
samples obtained during the convalescence phase and up to 74%
when using PCR. Time of seroconversion should be taken into
account when implementing detection procedures. Indeed there
is no control on the time between onset and admission and this
time might vary greatly from one patient to another. Time for
seroconversion should be taken into account when implementing
detection procedures. However, for practical reasons, admission
is the only time when blood samples can be taken since patients
can hardly be followed up after leaving the hospital. The best
solution would be therefore to implement multiplex PCR
detection on blood sample taken at admission. Cost of PCR is
nowadays not higher than that of serological tests and the pos-
sibility to combine several detection tests, i.e. dengue and chi-
kungunya, at the same time in a one-step single tube procedure
as well as the higher efﬁciency of PCR make it a highly cost-
effective option. A recommendation from this work would
therefore be to replace current procedures for serological
detection of dengue by a standard operating procedure for
DENV–CHIKV multiplex single step PCR.
26% of patients hospitalized with acute fever symptoms were
negative for both DENV and CHIKV. This unknown etiology
may need further work to identify what the causative pathogens
involved. Other limitations of this study is the limited number of
patients enrolled and therefore of samples available. Owing to
the dynamics of both chikungunya and dengue and the potential
of emergence for chikungunya in Vietnam it is of importance to
implement a larger surveillance system which will provide
valuable information on the prevalence and incidence of DENV
infection and CHIKV circulation which are essential for plan-
ning an appropriate public health strategy.
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